Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Biotech
Anthropic director Vas Narasimhan bets AI can speed Novartis R&D
Novartis CEO and Anthropic board director Vas Narasimhan suggests that improving drug R&D success rate will be a “10-year-plus journey” for AI.
Angus Liu
Nov 19, 2026 5:31pm
Novartis CEO says shareholders ‘happy overall’ despite setbacks
Nov 19, 2026 4:16am
DNA med-focused biotech Seawolf surfaces with $1.2B Sanofi pact
Nov 16, 2026 5:00am
Combo GCPR approach appears to reverse eye cancer signaling
Nov 12, 2026 10:00am
Amgen posts ph. 3 Sjögren’s data ahead of Novartis showdown
Nov 11, 2026 8:00am
AHA: Novartis’ Lp(a) drug shows zero benefit
Nov 7, 2026 9:50am